Article info

Download PDFPDF
Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease
  1. Correspondence to:
 J Borlak
 Drug Research and Medical Biotechnology, Fraunhofer Institute of Toxicology and Experimental Medicine, Nikolai-Fuchs-Strasse 1, D-30625 Hanover, Germany; borlakitem.fraunhofer.de
View Full Text

Citation

Reamon-Buettner SM, Borlak J
Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease

Publication history

  • Received April 9, 2004
  • Accepted April 13, 2004
  • First published September 1, 2004.
Online issue publication 
April 27, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.